142 related articles for article (PubMed ID: 18694393)
1. An overview of drug screening using primary and embryonic stem cells.
Eglen RM; Gilchrist A; Reisine T
Comb Chem High Throughput Screen; 2008 Aug; 11(7):566-72. PubMed ID: 18694393
[TBL] [Abstract][Full Text] [Related]
2. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
Eglen R; Reisine T
Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
[TBL] [Abstract][Full Text] [Related]
3. The use of immortalized cell lines in GPCR screening: the good, bad and ugly.
Eglen RM; Gilchrist A; Reisine T
Comb Chem High Throughput Screen; 2008 Aug; 11(7):560-5. PubMed ID: 18694392
[TBL] [Abstract][Full Text] [Related]
4. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?
Cezar GG
Curr Opin Chem Biol; 2007 Aug; 11(4):405-9. PubMed ID: 17662644
[TBL] [Abstract][Full Text] [Related]
5. Labeled stem cells as disease models and in drug discovery.
Ellerström C; Strehl R; Hyllner J
Methods Mol Biol; 2013; 997():239-51. PubMed ID: 23546761
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.
Thorne N; Malik N; Shah S; Zhao J; Class B; Aguisanda F; Southall N; Xia M; McKew JC; Rao M; Zheng W
Stem Cells Transl Med; 2016 May; 5(5):613-27. PubMed ID: 27034412
[TBL] [Abstract][Full Text] [Related]
7. From c-Photina mouse embryonic stem cells to high-throughput screening of differentiated neural cells via an intermediate step enriched in neural precursor cells.
Cainarca S; Fenu S; Bovolenta S; Arioli P; Menegon A; Lohmer S; Corazza S
J Biomol Screen; 2010 Oct; 15(9):1132-43. PubMed ID: 20834010
[TBL] [Abstract][Full Text] [Related]
8. Human cell systems for drug discovery.
Horrocks C; Halse R; Suzuki R; Shepherd PR
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):570-5. PubMed ID: 12951820
[TBL] [Abstract][Full Text] [Related]
9. Design and implementation of high-throughput screening assays.
Macarrón R; Hertzberg RP
Methods Mol Biol; 2009; 565():1-32. PubMed ID: 19551355
[TBL] [Abstract][Full Text] [Related]
10. High content screening for compounds that induce early stages of human embryonic stem cell differentiation.
Jee J; Jeon H; Hwang D; Sommer P; Park Z; Cechetto J; Dorval T
Comb Chem High Throughput Screen; 2012 Sep; 15(8):656-65. PubMed ID: 22364550
[TBL] [Abstract][Full Text] [Related]
11. Assay technologies for screening ion channel targets.
Mattheakis LC; Savchenko A
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318
[TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cells as a source of models for drug discovery.
Pouton CW; Haynes JM
Nat Rev Drug Discov; 2007 Aug; 6(8):605-16. PubMed ID: 17667955
[TBL] [Abstract][Full Text] [Related]
13. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
14. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
Donato MT; Tolosa L
Differentiation; 2019; 106():15-22. PubMed ID: 30844688
[TBL] [Abstract][Full Text] [Related]
15. Conference Report: update on screening methodologies.
Bardera AI; Martin J
Future Med Chem; 2009 May; 1(2):253-6. PubMed ID: 21425968
[TBL] [Abstract][Full Text] [Related]
16. Introduction: cell-based assays for high-throughput screening.
An WF; Tolliday NJ
Methods Mol Biol; 2009; 486():1-12. PubMed ID: 19347612
[TBL] [Abstract][Full Text] [Related]
17. Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators.
Trivedi S; Dekermendjian K; Julien R; Huang J; Lund PE; Krupp J; Kronqvist R; Larsson O; Bostwick R
Assay Drug Dev Technol; 2008 Apr; 6(2):167-79. PubMed ID: 18078380
[TBL] [Abstract][Full Text] [Related]
18. Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.
Martin J
Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.13. PubMed ID: 22294376
[TBL] [Abstract][Full Text] [Related]
19. Impact of new technologies for cellular screening along the drug value chain.
Möller C; Slack M
Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
[TBL] [Abstract][Full Text] [Related]
20. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
